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A B S T R A C T
Population-based screening studies suggest an overall prevalence of coeliac disease in Western
populations of about 1%. A variety of neurological problems have been associated with coeliac disease
occurring in up to 10% of cases of adult coeliac disease. We report an interesting case of a patient with
coeliac disease who subsequently developed neurological symptoms several years later. Furthermore, a
literature review of all cases to date was performed.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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A 63-year-old white woman presented with a 12-month history
of progressive tremor, unsteadiness and jerks of limbs. She was
diagnosed with coeliac disease by biopsy 30 years previously. This
was refractory in nature with intermittent diarrhoea and signiﬁ-
cant weight loss. She also had late onset complex partial seizures
diagnosed 4 years previously, pernicious anaemia and osteoarthri-
tis. Her medication included low dose steroids, carbamazepine
700 mg daily, vitamin B12 and folate. On examination she scored
30/30 on MMSE. She had myoclonus, tremor and ataxia. The
myoclonus and tremor were worse in the upper limbs, present at
rest, action and on sustained postures and were made worse with
activity. The ataxia was predominantly in the limbs and was
bilateral. She also had peri-oral tremulous movements. Cranial
nerves, sensory examination, reﬂexes and the rest of the
neurological examination were normal.
Blood tests showed low albumin and calcium, raised alkaline
phosphatase and AST. She had weakly positive ANA (titre 1/40).
Vitamin B12, folate, serum lactate, caeruloplasmin were within
normal limits. Antibodies to ANA and ENA and thyroid peroxidase
were negative. Antiendomysial IgA and antigliadin were negative.* Corresponding author. Tel.: +44 7779148342.
E-mail address: Shehzada50@doctors.org.uk (S. Javed).
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anti-amphiphysin, and those against voltage gated calcium and
potassium channels were negative. Genetic tests for Huntington’s
disease, mitochondrial disorders (including MELAS mutation 3243,
MERRF mutation 8345, NARP mutation 8993 and common
duplications and deletions) were negative. CSF analysis showed
4 white cells, with normal protein and glucose. Oligoclonal bands
were present. CT head, CT abdomen and chest X-ray were normal.
As she was claustrophobic MRI could not be done after onset of
tremor and ataxia. But an MRI done 4 years earlier (when seizures
began) showed nonspeciﬁc ischemic changes in cerebral hemi-
spheres and subtle early vermian and bilateral cerebellar
hemispheric atrophy was suspected.
Carotid Doppler and 24 h ECGs were normal. EEG showed right
anterior and mid temporal spike and waves and bilateral slow
waves and sharp waves. Some of these spike waves discharges
were associated with focal jerks of left arm and leg; there were no
periodic complexes. Tibial somatosensory evoked potentials
showed giant SEPs (Fig. 1).
Many medications were tried over the subsequent 2 years to
control the myoclonus but were poorly tolerated. Sodium
valproate caused encephalopathy; clobazam was associated with
drowsiness, lamotrigine with rash and zonisamide caused confu-
sion. Levetiracetam was well tolerated however this did not
control the myoclonus effectively. She was seen by gastroenter-
ologists and in attempts to control the coeliac disease thevier Ltd. All rights reserved.
Fig. 1. Tibial somatosensory evoked potentials showed giant SEPs.
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days, along with azathioprine 100 mg daily. Over the next 2 years,
she developed progressive cognitive problems along with deterio-
ration in mobility and disabling myoclonus requiring 24-h care.
She died following a cardio-respiratory arrest at home 6 years after
the onset of neurologic symptoms and 33 years after the diagnosis
of coeliac disease.
2. Discussion
We believe that the patient had refractory coeliac disease which
is linked to her progressive neurological condition. Though
causality is still not proven, several strands of evidence (immuno-
logical, histological and treatment response) support this concept
including several similar reports.
Coeliac disease, gluten ataxia and dermatitis herepetiformis are
the three gluten related autoimmune disorders.1 Coeliac disease is
characterized by malabsorption, structural abnormalities of small
bowel mucosa such as villous atrophy, crypt hyperplasia and
inﬂammation, and intolerance to gluten protein. In 1966, Cooke
and Smith reported 16 patients with neurological complications of
coeliac disease.2 A variety of neurological problems have been
associated with coeliac disease occurring in up to 10% of cases of
adult coeliac disease.3 These include peripheral neuropathy,
myelopathy, encephalopathy and cerebellar ataxia.2,3 In 1980
the ﬁrst case of progressive myoclonic ataxia syndrome and coeliac
disease was reported.3 At ﬁrst this was thought to be a chance
association as coeliac disease is common in the Caucasian
population affecting 1 in 100 people.4 However, further cases
were reported and they are summarized below. A literature search
for cases with progressive myoclonus and ataxia associated with
coeliac disease was performed through medline with search terms‘coeliac’ and ‘myoclonus’ and ‘ataxia’ identifying 15 cases in total
(Table 1).
Our patient too had a characteristic phenotype dominated by
action myoclonus and ataxia. As in some of the previous cases,
electrophysiological assessment revealed a cortical origin for the
myoclonus. Our patient had a biopsy diagnosis of coeliac disease,
but antiendomysial and antigliadin antibody were negative. Four
previous cases have also been antibody negative. The prevalence of
seronegative coeliac disease is 6.4–9.1% of all diagnosed cases.15
These patients tend to be older and have more severe disease.16
Ataxia can also occur in the absence of coeliac disease. Gluten
ataxia was originally deﬁned as otherwise idiopathic sporadic
ataxia with positive serological markers for gluten sensitization.17
It is an auto-immune disease where damage to the cerebellum
leads to ataxia. Recent studies have shown patients with gluten
ataxia have deposits of anti-tissue transglutamase (anti-TTG)
antibodies on brain vessels supporting the hypothesis that anti-
TTG antibodies may affect the functioning of the blood–brain
barrier.
Neurological disorders are only part of the wide spectrum of
immunological conditions associated with coeliac. In one study 63
out of 314 patients (20%) with coeliac disease were found to have
additional immunological disorders.18 Autoimmune disease in
general occurs more frequently in patients with coeliac disease
compared with the normal population. These include autoimmune
thyroid disease, type 1 diabetes mellitus, autoimmune liver
diseases and inﬂammatory bowel disease. Prevalence of coeliac
disease was noted to be 1–19% in patients with type 1 diabetes
mellitus, 2–5% in autoimmune thyroid disorders and 3–7% in
primary biliary cirrhosis in prospective studies.19
Some reports have demonstrated an improvement in neuro-
logical complications with a gluten free diet. Hadjivassilou et al.
Table 1
A summary of cases from the literature with progressive myoclonus and ataxia associated with coeliac disease.
Case
number
Author Age and
gender
Neurological features Antigliadin
antibodies
Time to onset of neurologi-
cal symptoms from onset
of gastrointestinal symp-
toms (years)
Response of
coeliac disease
to treatment
Electrophysiology
1 Bhatia et al. (1995)5 68F Action and stimulus sensitive
myoclonus, sensory neuropathy,
upper limb ataxia.
Negative 7 Good Cortical reﬂex myoclonus
2 Bhatia et al. (1995)5 44M Action and stimulus sensitive
myoclonus, gait and limb ataxia
Negative 19 Good Cortical reﬂex and action
myoclonus
3 Bhatia et al. (1995)5 52M Action myoclonus, seizures and
mild ataxia
Negative 25 Good Cortical reﬂex myoclonus
4 Bhatia et al. (1995)5 66M Action myoclonus, frequent
seizures, cerebellar ataxia
Negative 10 Good Multifocal polyspike
and slow waves
5 Finelli et al. (1980)3 56M Palatal myoclonus, cerebellar
ataxia, internuclear
opthalmoplegia
Not done 0 Nil Not done
6 Kinney et al. (1982)6 56M Diffuse myoclonus, ataxia,
dementia
Not stated 1 Nil Not done
7 Lu et al. (1986)7 42M Action myoclonus limbs,
seizures, ataxia
Not stated Neurological symptoms
preceded GI symptoms by
1 year
Good Cortical reﬂex and action
myoclonus
8 Lu et al. (1986)7 54F Action myoclonus of limbs,
seizures, ataxia
Not stated Neurological symptoms
preceded GI symptoms
by 5 years
Not reported No cortical correlates
9 Brucke et al. (1988)8 45M Arm, tongue and palatal
myoclonus, Ataxia
Positive 0 Not reported Not done
10 Tison et al. (1989)9 56F Arm, neck, face stimulus
sensitive + palatal myoclonus,
cerebellar ataxia
Positive 0 Good Cortical reﬂex myoclonus
11 Hanagasi et al. (2000)10 31F Gait ataxia stimulus-induced
myoclonus, abnormalities of eye
movement
Positive Neurological symptoms
preceded GI symptoms
by 5 years
Not reported Normal
12 Chinnery (1997)11 20F Stimulus sensitive and action
myoclonus.
Positive No GI symptoms. Diagnosis
of coeliac made 12 years
after neurological symptoms
Poor Not done
13 Fung (2000)12 48F Unilateral limb tremor, dystonia,
myoclonus and ataxia
Positive 46 Not reported Cortical action myoclonus
14 Mumford (1996)13 44M Myoclonic ataxia, seizures Not stated 0 Poor Focal cortical myoclonus
15 Sallem (2009)14 46F Generalised seizures, myoclonus
and ataxia
Positive Not stated Poor Generalised polyspike
wave complexes
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year there was a signiﬁcant improvement in ataxia in patients
treated with a gluten-free diet compared to the control group. The
diet associated improvement was apparent irrespective of the
presence of an enteropathy.20 Unfortunately, our patient did not
improve with a gluten free diet. Immunosuppressant drugs have
been tried but with inconclusive evidence.18 Our patient was on
prednisolone and azathioprine with no improvement in her
neurological function.
In conclusion, we report a case of progressive neurological
disorder in association with coeliac disease. We feel that the
possibility of a gluten related disorder needs to be explored when
unexplained neurological symptoms such as seizures, tremor,
ataxia or myoclonus occur. In our case the epilepsy developed 26
years, and myoclonus and ataxia 29 years after the diagnosis of
coeliac disease. Despite the lack of response to treatment, our
patient and her family were grateful for an explanation for her
condition.
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